Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Gemcitabine in the Treatment of Unknown Primary Tumors (Phase II)
2005-000452-32Phase 2Terminated
- Sponsor
- Istituti Fisioterapici Ospitalieri
- Start
- Mar 2006
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel and gemcitabine in cancer of unknown primary (CUP) and cancer, sponsored by Istituti Fisioterapici Ospitalieri. Started Mar 2006; status: terminated.
02
Drugs
docetaxelgemcitabine
03
Conditions
cancer of unknown primary (CUP)cancer
Beyond the preview
Go deeper on 2005-000452-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000452-32.